共 50 条
- [31] A Dual apoC-II mimetic-apoC-III Antagonist Peptide for Lowering Plasma TriglyceridesARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2019, 39Wolska, AnnaLo, LarrySviridov, Denis O.Pourmousa, MohsenPryor, MiltonGhosh, Soumitra S.Kakkar, RahulDavidson, MichaelWilson, SierraPastor, Richard W.Tang, JingrongAmar, MarceloDevalaraja, MattRemaley, Alan T.
- [32] APOLIPOPROTEIN C-II DEFICIENCY - IDENTIFICATION OF A STRUCTURAL VARIANT APOC-IIPADOVABIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 154 (01) : 73 - 79FOJO, SSBAGGIO, GGABELLI, CHIGUCHI, KBOJANOVSKI, MGREGG, REBREWER, HB
- [33] Specificity of the lipid-binding domain of apoC-II for the substrates and products of lipolysisJOURNAL OF LIPID RESEARCH, 2001, 42 (04) : 553 - 562Dahim, MMomsen, WEMomsen, MMBrockman, HL
- [34] ApoC-II Mimetic Peptide Blunts Post-Prandial Hypertriglyceridemia in MiceARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37Wolska, AnnaSakurai, ToshihiroSviridov, DenisPryor, MiltonLo, LarryGhosh, SoumitraDevalaraja, MadhavRemaley, Alan T.
- [35] Effect of CETP Inhibition With Anacetrapib on VLDL Triglyceride and Plasma ApoC-II, ApoC-III and ApoE MetabolismCIRCULATION, 2016, 134Millar, John S.Lassman, Michael E.Pavlyha, MariannaNgai, ColleenFontanez, NelsonRamakrishnan, RajasekharJumes, PatriciaDunbar, RicharddeGoma, Emile M.Baer, Amanda L.Karmally, WahidaDonovan, Daniel S.Rafeek, HashmiJohnson-Levonas, Amy O.Wagner, JohnHolleran, StephenLiu, YangAoujil, SoumiaStandiford, TaylorGutstein, David E.Ginsberg, Henry N.Rader, Daniel J.Reyes-Soffer, Gissette
- [36] Efficacy of ApoC-II Mimetic Peptide in Novel Apoc2 Mutant Mice With Hypertriglyceridemia and Impaired Insulin SensitivityARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36Sakurai, ToshihiroSakurai, AkikoVaisman, Boris L.Amar, Marcelo J.Liu, ChengyuGordon, Scott M.Drake, Steven K.Pryor, MiltonSampson, Maureen L.Yang, LingFreeman, Lita A.Noguchi, AudreyRemaley, Alan T.
- [37] APOC-IIPARIS2 - A PREMATURE TERMINATION MUTATION IN THE SIGNAL PEPTIDE OF APOC-II RESULTING IN THE FAMILIAL CHYLOMICRONEMIA SYNDROMEJOURNAL OF LIPID RESEARCH, 1992, 33 (03) : 361 - 367PARROTT, CLALSAYED, NREBOURCET, RSANTAMARINAFOJO, S
- [38] A Cyclic Peptide Inhibitor of ApoC-II Peptide Fibril Formation: Mechanistic Insight from NMR and Molecular Dynamics AnalysisJOURNAL OF MOLECULAR BIOLOGY, 2012, 416 (05) : 642 - 655Griffin, Michael D. W.Yeung, LeviHung, AndrewTodorova, NevenaMok, Yee-FoongKaras, John A.Gooley, Paul R.Yarovsky, IreneHowlett, Geoffrey J.
- [39] QUANTIFICATION OF APOC-II AND APOC-III OF HUMAN VERY LOW-DENSITY LIPOPROTEINS BY ANALYTICAL ISOELECTRIC-FOCUSINGJOURNAL OF LIPID RESEARCH, 1978, 19 (08) : 1047 - 1052CATAPANO, ALJACKSON, RLGILLIAM, EBGOTTO, AMSMITH, LC
- [40] A Novel APOC2 Missense Mutation Causing Apolipoprotein C-II Deficiency With Severe Triglyceridemia and PancreatitisJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (05): : 1454 - 1457Ueda, MasakoDunbar, Richard L.Wolska, AnnaSikora, Tracey U.Escobar, Maria del RosarioSeliktar, NaomideGoma, EmilDerOhannessian, StephanieMorrell, LindaMcIntyre, Adam D.Burke, FrancesSviridov, DenisAmar, MarceloShamburek, Robert D.Freeman, LitaHegele, Robert A.Remaley, Alan T.Rader, Daniel J.